An open randomised study of the efficacy of standard radiotherapy with and without the addition of SRL 172 (Mycobacterium vaccae) in the treatment of patients with small cell lung cancer (SIRON 13)
Phase of Trial: Phase II
Latest Information Update: 25 Apr 2008
At a glance
- Drugs IMM-201 (Primary) ; Antineoplastics
- Indications Small cell lung cancer
- Focus Therapeutic Use
- 16 Feb 2006 New trial record.